aspirin and ono-ae1-329

aspirin has been researched along with ono-ae1-329 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Heinemann, A; Konya, V; Lippe, IT; Marsche, G; Peskar, BA; Philipose, S; Schuligoi, R; Sreckovic, I	1

Other Studies

1 other study(ies) available for aspirin and ono-ae1-329

Article	Year
The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation. Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:12 Topics: Aspirin; Blood Coagulation; Blood Platelets; Calcium; Dinoprostone; Dose-Response Relationship, Drug; Fibrinogen; Fibrinolytic Agents; Flow Cytometry; Humans; Methyl Ethers; Naphthalenes; P-Selectin; Phenylbutyrates; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Prostaglandin E, EP4 Subtype; Thrombosis	2010

Article

Year

The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation.

Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:12

Topics: Aspirin; Blood Coagulation; Blood Platelets; Calcium; Dinoprostone; Dose-Response Relationship, Drug; Fibrinogen; Fibrinolytic Agents; Flow Cytometry; Humans; Methyl Ethers; Naphthalenes; P-Selectin; Phenylbutyrates; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Prostaglandin E, EP4 Subtype; Thrombosis

2010